ASIC Corporations (Application Form Requirements) Instrument 2017/241

This instrument rests on a small set of repeating legal concepts and defined terms. Those concepts determine entitlements to relief and the operational steps required to rely on it.

• Exemption from s 1016A (PDS delivery on issue) and s 723 (application form content): Central to the instrument is a carve‑out from the statutory application-form and restricted-issue/sale PDS rules where specific transaction types and process requirements are met (see ss 5, 5A, 5B, 6, 7). The relief is partial and conditional; it does not remove other statutory obligations (for example, advertising or other Chapter 6D duties may still apply, but sometimes in a modified form , see s 8).

• "Voluntary switch arrangement" and "member approved switch arrangement": The instrument defines two forms of switching arrangements in s 4. A voluntary switch arrangement is a bilateral written arrangement between the responsible entity and a member setting out when a member’s switch application may be accepted (s 4 definition). A member approved switch arrangement is a written arrangement entered into following member approval by vote where all members will switch all or part of their interests to another scheme operated by the same responsible entity or related body corporate (s 4 definition). The distinction matters because the timing for the required PDS delivery differs: for voluntary arrangements the PDS must be given before the time of the switch application; for member approved arrangements it must be given before the time of the vote (ss 5(2)(a)-(b)).

• "Relevant time" and PDS not defective: The relief is conditional on a PDS or Short‑Form PDS being given or made available by a nominated electronic means and that the Statement was "not defective" at the relevant time (ss 5(2)(c), 5B(2)). "Defective" is defined by reference to s 1021B(1) of the Act (s 4). The timing rule is therefore legal: the PDS must be non-defective when it was provided or made available, not merely afterwards.

• "Reasonable steps" and "reasonable grounds": The instrument repeatedly uses the statutory standards "reasonable steps" (for obtaining the exemption , ss 5(2), 5A(2), 5B(2)) and "reasonable grounds" (for relying on licence-personalised application forms , s 9(1B) and s 9(2B)). These are fact‑dependent standards that shift the onus onto the issuer/responsible entity/licensee to take and document steps sufficient to establish compliance.

• Nominated electronic means: The instrument permits making PDSs available by "nominated electronic means" (ss 5(2)(c), 5A(2)(c), 5B(2)). The definition of that phrase is "the same meaning as in section 9 of the Act as notionally modified or varied by ASIC Corporations (Electronic Disclosure) Instrument 2025/447" (s 4). The cross‑reference imports the electronic delivery regime, so the precise mechanics of "making available" depend on that separate instrument.

• Eligible reconstructions and eligible foreign countries: Section 4 defines “eligible foreign country” and “eligible reconstruction,” and makes a note that a separate ASIC instrument (Compromises or Arrangements) 2025/613 affects whether particular jurisdictions are eligible for reconstructions. Section 6 then uses eligible reconstructions and capital reduction offer classes to exempt offers under those particular corporate restructurings from the application form rule (s 6(1)) and relief from s 1016A(2) where an issue or sale results from such an offer (s 6(2)).

• Pro-rata bonus offers of options: Section 7 exempts pro‑rata bonus issues of options from the application-form rule in s 723 and exempts responsible entities from s 1016A(2) for pro‑rata option grants over scheme interests where the interests form part of stapled securities and shares in a body also form part (s 7(2)). Advertising relief is conditional and includes stated requirements (s 7(3)). The instrument also expressly notes that subsection 727(2) of the Act (which prohibits offers of options that require disclosure unless accompanied by a disclosure document) remains relevant (note to s 7(1)).

• Licence personalised application forms: Section 9 inserts notional subsections into s 723 and s 1016A to permit application forms that are partly or wholly prepared by financial services licensees and distributed to applicants, subject to the issuer having reasonable grounds that the applicant contemporaneously had access to the disclosure document and that the application form contained specified identity, financial product and disclosure-document information. The notional insertion sets out explicit content requirements the form must include (see s 9(1A), (1B), (2A), (2B)).

• Modifying Chapter 6D advertising requirements for reconstructions and capital reductions: Section 8 modifies how s 734 applies in relation to person offering securities under the s 6(1) exemption by omitting certain subparagraphs and varying paragraph 734(6)(d). That materially narrows some prescribed advertising content required for such offers.

• Interaction with Part 7.9 and CCIV-specific sections: The instrument repeatedly modifies the application of Part 7.9 (division on managed investment product application forms) and notes that Part 7.9 applies to CCIVs with statutory modifications (see notes referencing sections 1241W and 1241S). Section 10 modifies a regulation requirement for including the applicant's date of birth (Reg 7.9.74(1)(b) as notionally inserted) to allow a statement that the applicant is at least 18.

These concepts recur throughout the instrument and determine the scope of permissible alternatives to the ordinary application-form/PDS delivery rules. Each relief is conditional and the instrument generally ties relief to demonstrable acts (giving or making available PDS, including specified information on application forms, and maintaining reasonable grounds/steps).

The instrument touches a defined set of market participants and intermediaries. The primary actors who bear the instrument’s obligations, choices and compliance costs are:

• Responsible entities of registered schemes: Sections 5 and 7(2) explicitly provide exemptions and conditions targeted at responsible entities when issuing new interests as part of switches between schemes they operate, or when granting pro‑rata options over scheme interests that form part of stapled securities. A responsible entity electing to rely on the exemptions is required to take "reasonable steps" to give or make available a non‑defective PDS or Short‑Form PDS at the relevant time and to provide information describing the switch arrangement (s 5(1)-(2); s 7(2)).

• Operators of notified foreign passport funds: Section 5A mirrors s 5 for notified foreign passport funds, so operators of those funds that operate intra‑operator switches are affected by the same conditions: must give/make available a non‑defective PDS and descriptive information before the relevant time (s 5A(1)-(2)).

• Corporate director of a retail CCIV and the retail CCIV itself: Section 5B applies to retail CCIVs, placing the onus on the corporate director to take reasonable steps to ensure a PDS or Short‑Form PDS that was not defective at the relevant time was given or made available and that information describing the switch arrangement was provided (s 5B(1)-(2)). The corporate director, not merely the CCIV manager, is the statutory actor required to take steps.

• Issuers and sellers involved in reconstructions and capital reductions: Section 6 provides relief from s 723 and s 1016A(2) for offers of securities made under eligible reconstructions, Part 2J.1 capital reductions or foreign capital reduction offers. That affects companies, bodies and responsible entities engaged in those corporate restructuring transactions and their advisers who normally prepare application forms and PDSs (s 6(1)-(2)).

• Bodies issuing pro‑rata options over shares: Section 7(1) exempts a body from s 723 in relation to a pro‑rata bonus offer of options over shares, and triggers advertising content obligations (s 7(1), (3)). Bodies that are part of stapled structures and whose interests are stapled with scheme interests are caught by s 7(2).

• Financial services licensees distributing application forms: Section 9 permits licensees to distribute personalised application forms , either partially completed or derived from issuer-provided forms , but only where the issuer has reasonable grounds to believe the applicant had contemporaneous access to the disclosure document and the application form contains specified identity and disclosure-document summary information (s 9(1A), (1B), (2A), (2B)). That affects dealer groups, platforms, advisers and AFSL holders that distribute forms.

• Investors and members: Indirectly, investors and members are affected in their receipt of PDS material and the mechanics of applying for securities or switching between schemes. Under the instrument, members may be asked to rely on electronic availability of PDSs rather than physical paper delivery at the time of applying, or to fill in application forms prepared or adapted by licensees (ss 5, 9).

• Advertisers and communications teams: Entities that prepare pre‑ and post‑lodgement advertisements for pro‑rata options and for offers under reconstructions or capital reductions must include the statements required by s 7(3) and must observe modified s 734 requirements as set out in s 8.

Who pays and who decides

• The financial cost of compliance falls on the issuers/responsible entities/operators/corporate directors/licensees who must take the “reasonable steps” and maintain records to show compliance. Those entities decide whether to rely on the instrument’s exemptions and must judge whether their acts qualify as "reasonable steps" or give them "reasonable grounds" as the instrument requires (ss 5, 9).
• Investors bear indirect costs in the form of reliance risk where PDS availability is electronic and the issuer relies on "reasonable grounds" that the investor had access. That may affect the investor’s ability to make an informed choice if the PDS was not in fact accessed or was defective at the relevant time.

Geographical and product scope constraints

• The instrument limits eligible reconstructions to those regulated by or under laws of particular "eligible foreign countries" listed in s 4, and it differentiates between eligible countries for reconstructions and for foreign capital reduction offers (s 4 definition and accompanying note). That constrains cross‑border applicability.
• The relief is product-specific , e.g. registered scheme interests, notified foreign passport fund interests, CCIV shares, pro‑rata options , so entities dealing in other financial products are not covered unless a specific provision applies.

Recordkeeping, systems and operational teams affected

• Compliance, legal and operations teams in responsible entities, fund operators and licensees will need to adapt processes to capture timestamped evidence of PDS availability, to ensure that application forms contain the required content, and to certify "reasonable grounds" where required (ss 5(2), 9(1B), 9(2B)). Systems for electronic distribution (nominated electronic means) will be implicated by the cross‑referenced Electronic Disclosure Instrument 2025/447 (s 4).

In short, the instrument reallocates procedural responsibilities across issuers, responsible entities and licensees in specific transaction types, and imposes an operational burden on those entities to establish the preconditions for relief and to document compliance in an environment where electronic delivery mechanisms and the timing of disclosure are determinative.

This instrument creates conditional duties for issuers, responsible entities, operators and licensees and rights to rely on exemptions where those duties are met. The operative provisions and their associated duties and rights are as follows.

Duties on responsible entities, operators and corporate directors to secure exemptions

• Duty to take reasonable steps to provide a non‑defective Statement and information describing a switch arrangement. For switches between schemes operated by the same responsible entity (s 5), notified foreign passport funds (s 5A), or sub-funds of a retail CCIV (s 5B), the responsible entity/operator/corporate director must have taken "reasonable steps" to ensure that a Product Disclosure Statement or Short‑Form PDS for the new interest was given or made available by a nominated electronic means and was not defective at the relevant time, and that information describing the switch arrangement was also given or made available (ss 5(2)(c)-(d), 5A(2)(c)-(d), 5B(2)). The timing of those steps differs depending on whether the arrangement is voluntary or member‑approved (ss 5(2)(a)-(b), 5A(2)(a)-(b), 5B(2)).

• Duty to ensure PDS is not defective at the relevant time. The instrument specifies that the PDS must not have been "defective" at the relevant time, using the definition in s 1021B(1) (s 4). That is a legal standard drawn from the Act.

• Duty to satisfy content and delivery standards for licence-personalised forms. Under the notional insertions into s 723 and s 1016A effected by s 9, where a licence-personalised application form is used the issuer/transferor must have reasonable grounds to believe (a) that when the applicant received the form they were given access, at the same time and by the same means, to the disclosure document; and (b) the application form included specified information (identity of issuer, nature of securities/financial products, price, date and expiry of the disclosure document and a prominent statement to read the disclosure document) (s 9(1B)(a)-(b) and s 9(2B)(a)-(b)). The same content requirements are set out for Part 7.9 contexts (s 9(2B)(b)(i)-(ii)).

• Duty to include applicant age information or DOB. Section 10 requires application forms to include either the applicant’s date of birth or a statement that the applicant is at least 18, by notionally modifying paragraph 7.9.74(1)(b) of the Corporations Regulations.

Rights to rely on exemptions

• Responsible entities, operators and retail CCIV corporate directors have the right not to comply with section 1016A in relation to the issue of new interests where the conditions in ss 5, 5A or 5B are met (ss 5(1), 5A(1), 5B(1)). That is a right to relief from the statutory PDS delivery obligation in limited, defined circumstances.

• Persons conducting eligible reconstructions or capital reductions have the right not to comply with s 723 (application-form requirement) for offers under eligible reconstructions, Part 2J.1 capital reductions, and foreign capital reduction offers (s 6(1)), and issuers/sellers need not comply with s 1016A(2) where the issue/sale results from such an offer (s 6(2)).

• Bodies conducting pro‑rata bonus offers of options have the right not to comply with s 723 in relation to that offer (s 7(1)). Responsible entities have a narrow right not to comply with s 1016A(2) for pro‑rata bonus options over scheme interests where those interests are stapled with shares in a body (s 7(2)).

• Licensees and issuers have the right to use licence-personalised application forms if they comply with the notional modifications and the issuer has reasonable grounds to believe the applicant had access to the disclosure document and the form included the required information (s 9(1A)-(1B); s 9(2A)-(2B)).

Limits, procedural conditions and interplay with other duties

• Advertising and publicity obligations under s 734 of Chapter 6D remain relevant. Section 8 declares that Chapter 6D applies to persons making offers under s 6(1) as if s 734 were modified or varied by omitting particular subparagraphs (734(5)(a)(vi), 734(5)(b)(iii) and paragraph 734(6)(e)) and replacing a conjunction in 734(6)(d) with a full stop. That narrows the required information in advertisements for those reconstruction and capital reduction offers, but it does not eliminate all advertising obligations (s 8).

• The instrument expressly cross-references existing prohibitions: for pro‑rata bonus options, the instrument includes a note that subsection 727(2) of the Act (prohibiting an offer of options that needs disclosure under Part 6D.2 unless the offer is included in or accompanied by a disclosure document) still applies (note to s 7(1)). Thus the exemptions in the instrument do not override other express statutory prohibitions.

• The relief is conditional on content and timing. For switches, the PDS must be given or be made available at specific points in time (before the switch application for voluntary arrangements or before the vote in member-approved arrangements) and must not be defective at those times (s 5(2)). These are operationally meaningful limits on the right to rely on the exemption.

Evidential and documentation duties

• Implicit in the "reasonable steps" and "reasonable grounds" requirements is a duty to create and retain contemporaneous evidence showing that those standards were met. Although the instrument does not set explicit recordkeeping periods, the practical operation of the instrument gives rise to documentation duties on issuers, responsible entities and licensees (ss 5, 9).

Overall, the instrument converts policy flexibilities into rights to non‑compliance with particular statutory rules, but the rights are conditional on procedural and timing duties that require proactive steps and recordable acts by the market participants wishing to rely on the relief.

The instrument itself does not create separate criminal or civil penalties; it operates by modifying how existing provisions of the Corporations Act apply. Consequently enforcement and penalty risks flow from failure to meet the statutory conditions or from contraventions of the Act where the instrument does not relieve the actor. The enforcement architecture that applies is therefore the pre‑existing Corporations Act framework, including civil penalties, criminal offences, breach reporting obligations and ASIC’s regulatory powers.

How enforcement links to the instrument’s conditions

• If a responsible entity or issuer claims an exemption under ss 5, 5A, 5B, 6 or 7 but fails to satisfy the conditional requirements , for example, the PDS was defective at the relevant time, or the issuer cannot show it took "reasonable steps" , then the statutory rules from which relief was sought remain applicable and an issuer could be exposed to consequences under the relevant provisions of the Act. The instrument itself provides no safe harbour if its conditions are not actually met (see ss 5-7).

• Where the notional modifications to s 723 or s 1016A in s 9 are relied upon, the issuer must have "reasonable grounds" that the applicant had contemporaneous access to the disclosure document and that the application form contained the required content. If those reasonable‑grounds conditions cannot be demonstrated and the issuer proceeds as if relieved from s 723 or s 1016A, the issuer may be exposed to contraventions of the Act’s disclosure or application form rules, with the usual regulatory sanctions (s 9(1B), 9(2B)).

Types of enforcement remedies and penalties that remain relevant

• Civil penalties and injunctions, enforcement by ASIC for misleading or deceptive conduct, and remedies for breach of disclosure obligations under the Act remain available. The instrument does not extinguish ASIC’s powers; rather, it narrows the set of circumstances in which particular statutory duties apply. Where the instrument leaves duties intact (for instance, advertising obligations under s 734 not wholly removed but modified by s 8), contraventions of those duties can attract sanctions in the normal way.

• Substantive offences in the Act, such as those relating to fraudulent or dishonest conduct, are unaffected by the instrument. The notes and cross‑references in the instrument make clear that other statutory provisions apply where relevant , for instance, subsection 727(2) remains in force for option offers (note to s 7(1)). Breaches of those provisions can attract the criminal or civil penalties set out in the Act.

ASIC’s enforcement role and interpretative discretion

• ASIC enforces the Corporations Act and will assess whether market participants satisfied "reasonable steps" and "reasonable grounds". The instrument relies on those standards; therefore enforcement activity is likely to focus on whether the steps taken meet the standard in the circumstances. The instrument does not define "reasonable" in any particular way; that will be a matter for regulatory assessment and, potentially, court determination in the event of disputes (ss 5, 9).

Practical compliance and enforcement risk

• The operational consequence is that entities choosing to rely on the instrument must be prepared to show contemporaneous evidence (for example, timestamps for electronic making available of PDS, logs showing licence-personalised forms were accompanied by links to PDS etc.) because those records will be the primary basis on which ASIC or a court assesses whether the issuer met the statutory standards. Failure to keep or produce that evidence increases exposure to enforcement action for contravening the primary disclosure and application-form provisions the instrument seeks to modify (ss 5, 9).

In short, the instrument does not itself create new penalties, but it modifies the circumstances in which existing duties apply and reassigns the evidential burden to market participants. Enforcement risk therefore centres on the factual question whether an issuer actually complied with the "reasonable steps" and "reasonable grounds" gateways the instrument sets out. Contraventions of unaffected or remaining statutory provisions (for example, s 727(2), modified s 734 duties) continue to attract the full sanctions provided by the Corporations Act.

This instrument is designed to operate within the existing architecture of the Corporations Act 2001 and related ASIC instruments. It repeatedly cross-references and notionally modifies provisions of the Act and is intended to be read alongside other ASIC instruments that regulate electronic disclosure and technical relief for reconstructions and capital reductions. The principal interactions are as follows.

Interaction with the Corporations Act: Chapter 6D and Part 7.9

• The instrument modifies how s 723 (application forms) and s 1016A (Part 7.9 restricted issues/sales and PDS delivery) operate in specified circumstances (ss 5-7, 9, 11). It does so by providing exemptions from those sections or by declaring that Chapter 6D and Part 7.9 apply as if modified to permit licence-personalised forms. Therefore the instrument should be read as situationally disapplying or varying the statutory text, but only where the instrument’s conditions are met.

• Advertising provisions (s 734 of Chapter 6D) are modified for reconstruction and capital reduction offers by s 8. The instrument omits particular subparagraphs of s 734 and alters paragraph 734(6)(d) in order to change the scope of required advertising content for those transactions.

Cross-references to definitions and offences within the Act

• The instrument relies on the Act’s definitions , e.g. "defective" defined at s 1021B(1) (s 4 note); "relevant financial product" as in s 1016A(1) (s 4). It therefore interacts with the Act’s existing interpretive framework, and any judicial or ASIC interpretation of those Act definitions will affect the instrument’s operation.

Interaction with other ASIC instruments

• The instrument relies on, and cross‑references, other ASIC instruments that change antecedent statutory meanings. For example, "nominated electronic means" is defined by reference to section 9 of the Act as notionally modified by ASIC Corporations (Electronic Disclosure) Instrument 2025/447 (s 4). That means the mechanics of making a PDS available electronically for the purposes of ss 5, 5A and 5B are governed by the separate Electronic Disclosure Instrument. Practitioners must consult that instrument to confirm what steps count as "making available".

• Section 6 notes that ASIC Corporations (Capital Reductions and Reconstructions,Technical Disclosure Relief) Instrument 2017/242 provides additional technical disclosure relief in relation to reconstructions and capital reductions. That separate instrument will affect the substantive disclosure that is required (or relief that is available) in those settings.

Interaction with CCIV provisions

• The instrument observes that Part 7.9 applies to CCIVs subject to modifications and cross‑references sections 1241W and 1241S (s 9 note and s 11 note). Section 5B specifically addresses retail CCIVs and places duties on the corporate director to take reasonable steps. Practitioners handling CCIVs must therefore reconcile this instrument with the CCIV‑specific modifications in the Act.

Interaction with foreign law regimes and cross-border items

• The definition of "eligible foreign country" in s 4 lists specific jurisdictions for reconstructions and a longer list for foreign capital reduction offers, with an explanatory note that certain jurisdictions are not eligible for reconstructions because a separate instrument (ASIC Corporations (Compromises or Arrangements) Instrument 2025/613) provides an exemption for hearings under those foreign laws. This means that the instrument’s reconstruction and capital reduction relief applies differently depending on which foreign law regime regulates the reconstruction or capital reduction.

Limits where other Act provisions continue to apply

• The instrument expressly preserves the operation of other relevant provisions of the Act. For example, for bonus options, s 7(1) includes a note pointing out that subsection 727(2) of the Act still prohibits offers of options requiring disclosure unless the offer is included in or accompanied by a disclosure document. Thus the instrument cannot be read to override independent statutory prohibitions.

Interaction with Corporations Regulations

• Section 10 notionally modifies paragraph 7.9.74(1)(b) of the Corporations Regulations 2001 to require an application form to contain a date of birth or a statement that the applicant is at least 18. Practitioners must reconcile this modified regulation language with existing regulation drafting and any other regulatory obligations concerning investor identity and suitability.

Definitions that import other statutory meanings

• The instrument imports definitions such as "defective" from s 1021B(1), and "issue" and "sale" are stated to be affected by ss 761E, 1010C, 1011C and 1010C of the Act where used in certain subsections (see s 4). That means that the instrument’s application may vary with how the Act defines those concepts in the contexts cited.

Practitioner consequence

• Because the instrument works by conditional modification and cross‑reference, a practitioner relying on its relief must consider the instrument together with the Act and the related ASIC instruments it references. The net legal outcome for any transaction will be the sum of: (a) the Act as modified by notional insertions referred to in the instrument; (b) the separate ASIC instruments (notably the Electronic Disclosure Instrument 2025/447 and the Capital Reductions and Reconstructions instrument 2017/242); and (c) any CCIV‑specific Act modifications. The instrument therefore does not stand alone; it shapes the legal outcome only in combination with the rest of the statutory and regulatory framework.

The instrument has been amended several times. The endnotes set out the registration and commencement dates for those amendments and identify which provisions were altered. The compilation date is 24 September 2025, and the endnotes show the amending instruments and their commencement dates (Endnote 3 and 4). The historical mechanics and key amendments are as follows.

Chronology of instruments and commencement dates (Endnote 3)

• Original instrument: ASIC Corporations (Application Form Requirements) Instrument 2017/241, registered 22 March 2017, commenced 23 March 2017.
• Amendment 2018: ASIC Corporations (Amendment) Instrument 2018/697, registered 13 September 2018, commenced 18 September 2018.
• Amendment 2022: ASIC Corporations (Amendment) Instrument 2022/0940, registered 14 November 2022, commenced 15 November 2022.
• Amendment and Repeal 2025/448: registered 18 September 2025, commenced 19 September 2025.
• Amendment and Repeal 2025/617: registered 23 September 2025, commenced 24 September 2025.

What was amended (Endnote 4 provides a provision-level summary)

• Section 2 was repealed by LA s 48D (Endnote 4 first line).
• Section 4 received multiple amendments (am 2018/697), including changes to definitions over time. Specific items amended in s 4 include:
  • The note to the definition of eligible foreign country was amended by 2025/617.
  • The definition of "member approved switch arrangement" was amended by 2022/0940.
  • The definition of "nominated electronic means" was amended by 2025/448.
  • The definition of "relevant financial product" was amended by 2022/0940.
  • The definitions of "switch" and "voluntary switch arrangement" were amended by 2022/0940.
• Section 5A (applications to switch between notified foreign passport funds) was added by 2018/697.
• Section 5B (applications to switch between sub-funds of a retail CCIV) was added by 2022/0940.
• Section 9(2) (note) and the notional paragraph 1016A(2B)(a) note were added or amended in 2022/0940 and 2025/448 respectively.
• Sections 10 and 11 were amended in 2018/697 and 2022/0940 (s 10 am 2018/697 and 2022/0940; s 11 note ad 2022/0940).

Substantive themes of the amendments

• Expansion of the exemption regime: The 2018 and 2022 amendments expanded the instrument’s reach beyond the original 2017 text by adding provisions for notified foreign passport funds (s 5A) and retail CCIV sub‑fund switches (s 5B), and by updating definitions of switch arrangements to capture different fund structures and the CCIV form.
• Electronic disclosure coordination: The 2025 amendments (2025/448, 2025/617) adjust the instrument to align with electronic disclosure reforms (notionally inserting a new definition of "nominated electronic means" that is tied to ASIC Corporations (Electronic Disclosure) Instrument 2025/447) and to refine international jurisdiction lists in light of separate instruments concerning cross‑border reconstructions (2025/613).
• Technical alignment with broader disclosure relief: The instrument has been revised to coordinate with ASIC’s separate technical relief for capital reductions and reconstructions (Instrument 2017/242) and with the CCIV regime amendments in the Corporations Act (as reflected by cross‑references to sections 1241W and 1241S).

Practical reading of amendment history

• A practitioner reading the instrument should consult the endnotes and the other instruments identified in the notes to ensure they have the current legislative architecture in view. The instrument’s amendments demonstrate an evolutionary approach: new product forms (CCIVs and foreign passport funds), electronic disclosure frameworks, and international jurisdictional issues were progressively incorporated.

Limitations of the amendment history in the compilation

• The compilation notes that uncommenced amendments are underlined in the endnotes and that modifications effected by other laws may not be reflected in the text of the compilation (see “About this compilation” preamble). To confirm current law for a particular date, practitioners should check the Register and the relevant amending instruments cited in Endnote 3.

In summary, the instrument began as a narrowly tailored application‑form relief measure in 2017 and has been extended and calibrated over time to accommodate new fund structures, electronic delivery regimes and cross‑border transaction contexts. The endnotes provide the authoritative amendment trail and identify the specific clauses changed by each amending instrument.

The text of this instrument and the compilation provided contain no cases, judicial decisions, or litigation history. The instrument itself is an administrative instrument of ASIC and the compilation’s endnotes do not cite any judicial determinations about this instrument. Therefore there is no litigation history recorded in the instrument’s text or endnotes.

Potential litigation focal points implied by the instrument

• Although there are no cases named in the instrument, the instrument creates factual gateways , "reasonable steps", "reasonable grounds", "not defective at the relevant time", and "making available by nominated electronic means" , that are classic focal points for regulatory disputes and litigation. In future litigation involving this instrument, courts or tribunals would likely be asked to determine:
  • What acts constitute "reasonable steps" by a responsible entity/operator/corporate director to show that a PDS was given or made available at the relevant time (see ss 5(2), 5A(2), 5B(2)).
  • What acts constitute "reasonable grounds" for an issuer to believe an applicant had contemporaneous access to the disclosure document where a licence-personalised form is used (s 9(1B), 9(2B)).
  • What it means for a PDS to be "not defective" at a particular time under s 1021B(1), because the instrument conditions relief on that standard (s 5(2)(c); s 5B(2)(a)).
  • Whether a particular electronic delivery mechanism satisfied the "nominated electronic means" standard as notionally modified by the Electronic Disclosure Instrument (s 4).
  • The scope of s 734 modifications for reconstructions and capital reductions under s 8, particularly whether a particular piece of advertising met the modified statutory requirements.

No cases named by the instrument

• The instrument does not identify or rely on precedent, and the endnotes do not refer to case law specific to the instrument. Any litigation that arises will therefore concern the interpretation and factual application of the statutory and instrument language, rather than an established body of instrument‑specific case law.

Practical implication for practitioners

• In the absence of binding case law on these instruments, issuers and advisers should assume that disputed matters (for example whether steps taken were reasonable) will be resolved by fact-based inferences from contemporaneous records. That raises the practical importance of documenting actions taken at the relevant times. It also means that litigated interpretations will gradually shape the practical meaning of the instrument’s standards; until then, the regulatory assessments by ASIC and the evidential record will be decisive in practice.

In sum, while there is no litigation history recited in the instrument, the instrument’s reliance on fact-dependent legal standards creates identifiable legal risk points where regulatory or judicial scrutiny could focus.

The instrument permits practical flexibilities but contains a number of traps for the unwary; the following are concrete operational and legal pitfalls drawn from the instrument’s text.

1. "Reasonable steps" and "reasonable grounds" are not defined

• The instrument repeatedly conditions relief on facts denoted by "reasonable steps" (ss 5(2), 5A(2), 5B(2)) and "reasonable grounds" (s 9(1B), s 9(2B)). Those are fact-dependent standards. There is no statutory safe harbour or checklist in the instrument that automatically satisfies the tests. Failure to create contemporaneous evidence demonstrating what steps were taken or why the issuer had reasonable grounds will make it difficult to resist an ASIC determination or a court finding that the exemption was not properly available.

2. PDS must be "not defective" at the relevant time

• The exemption for switches requires the PDS or Short‑Form PDS to have been "not defective" at the relevant time (s 5(2)(c); s 5B(2)(a)). "Defective" is an Act term referring to s 1021B(1). If a PDS subsequently becomes defective (for example due to a material omission discovered later), that will not retrospectively cure failure to meet the condition at the relevant time. Issuers must check the PDS content against the Act’s defective‑document criteria at the precise time set by the instrument (before switch application or before the vote depending on arrangement type).

3. Electronic delivery mechanics are imported from a separate instrument

• The instrument permits making PDS available by "nominated electronic means" but that phrase is defined by reference to s 9 as notionally modified by ASIC Corporations (Electronic Disclosure) Instrument 2025/447 (s 4). The Electronic Disclosure Instrument contains the operational mechanics for electronic delivery. Failure to follow that separate instrument’s requirements will mean the issuer did not "make available by a nominated electronic means" and therefore cannot rely on the relief (ss 5, 5A, 5B, s 4).

4. Narrow eligibility for foreign reconstructions and capital reductions

• The definition of "eligible foreign country" is precise and differs for reconstructions and foreign capital reduction offers (s 4). A jurisdiction that is eligible for capital reductions may not be eligible for reconstructions; the instrument flags that ASIC Corporations (Compromises or Arrangements) Instrument 2025/613 provides an exemption in some jurisdictions, meaning practitioners must map the foreign law to the instrument’s eligibility list to determine whether the s 6 exemption applies (s 4 note; s 6).

5. Pro‑rata bonus options relief does not override s 727(2)

• Section 7(1) exempts a body from s 723 for pro‑rata bonus offers of options, but the instrument includes an explicit note reminding readers that s 727(2) still prohibits an offer of options that needs disclosure under Part 6D.2 unless the offer is included in or accompanied by a disclosure document (note to s 7(1)). The net effect is that s 7(1) provides relief from the application form rule, but it does not nullify the substantive prohibition against making undisclosed offers of options. Practitioners must consider both provisions; relief from s 723 does not automatically authorise otherwise prohibited offers.

6. Stapled securities condition is narrow

• The relief in s 7(2) for responsible entities in relation to pro‑rata bonus offers of options applies only where the interests form part of stapled securities and shares in a body also form part of the stapled securities (s 7(2)(a)-(b)). Firms that assume broad relief for bonus options without confirming stapling structures risk non‑compliance. The stapling condition is a factual one that should be separately verified.

7. Licence-personalised forms create issuer evidentiary obligations

• Where application forms are created or distributed by licensees, the issuer must have reasonable grounds to believe the applicant had contemporaneous access to the disclosure document and that the application form included specified identity and disclosure-document information (s 9(1B)(a)-(b); s 9(2B)(a)-(b)). If the issuer relies on a licensee’s conduct without documenting the evidence that would support "reasonable grounds", the issuer may become exposed to contraventions of s 723 or s 1016A. Practical mistakes include failing to ensure the form contains the mandated statements or failing to capture an audit trail showing simultaneous access to the disclosure document.

8. Advertising relief is limited and conditional

• Section 7(3) permits certain advertising for pro‑rata bonus options only if the advertisement includes either an undertaking that a disclosure document will be made available or a statement that the offers will be made in or accompanied by the disclosure document, depending on timing relative to lodgement. Section 8 modifies s 734 for some reconstruction and capital reduction offers by omitting specified subparagraphs, but this is a careful, limited modification. Advertisers who simplify content on the assumption of blanket relief risk breaching the residual advertising requirements.

9. Changes over time and uncommenced modifications

• The instrument has been amended on multiple occasions (Endnote 3). Some amendments are notionally inserted or are contingent on other ASIC instruments. Practitioners must confirm the operative version on the Register and be alert to uncommenced amendments that may be noted in endnotes but not effectual in the text (see compilation preamble).

10. The instrument does not specify record retention or audit standards

• While the instrument makes the onus of proof practical (reasonable steps/reasonable grounds), it does not specify how long records must be kept or precisely what records suffice. That leaves issuers to select a recordkeeping standard. Failure to adopt a robust approach to contemporaneous records increases enforcement risk.

In short, the main traps are reliance on vague standards without proof, failure to apply the separate electronic-disclosure instrument, assuming blanket relief for options or advertising, and not checking the jurisdictional/structural conditions that the instrument makes central. Practical mitigation is documentary: log delivery actions, stamp PDS versions, ensure application forms meet content requirements, and verify that the transaction fits the instrument’s factual predicates before relying on the exemptions.

Compliance under this instrument is largely procedural: market participants must take identifiable pre‑emptive steps, maintain evidence, and ensure application forms include required content. The following checklist is operationally derived from the instrument’s text and indicates concrete actions, mapped to the relevant sections.

1. Determine whether the transaction falls within an instrument category

• Confirm whether the transaction is a switch covered by s 5 (registered schemes), s 5A (notified foreign passport funds), or s 5B (retail CCIV sub‑funds). Check whether the arrangement is a “voluntary switch arrangement” or a “member approved switch arrangement” as defined in s 4; the timing for PDS availability differs by type (s 5(2)(a)-(b), s 5A(2)(a)-(b), s 5B(2)).
• For restructurings, check whether the offer is an eligible reconstruction, a Part 2J.1 capital reduction offer, or a foreign capital reduction offer (s 6 and s 4 definitions). Verify whether the foreign law in question is listed as an eligible foreign country and note the instrument’s specific notes on those lists (s 4 note).
• For bonus options, verify whether the offer is a pro‑rata bonus offer and whether the scheme interests are part of stapled securities that include shares in a body (s 7(1)-(2)).

2. Prepare and validate the disclosure statement and timing

• Ensure the Product Disclosure Statement or Short‑Form PDS for the new interest exists and review it against s 1021B(1) to confirm it is "not defective" at the relevant time specified by the instrument (s 5(2)(c); s 5B(2)(a)). A pre-transaction compliance review of the PDS content should be documented.
• For voluntary switch arrangements, make the PDS available before the time of the switch application. For member approved switch arrangements, make the PDS available before the vote on the resolution approving the arrangement (s 5(2)(a)-(b)). Time‑stamp evidence of availability to establish compliance with the "relevant time" requirement.

3. Use compliant electronic delivery methods and evidence them

• Where the PDS is made available by electronic means, comply with the requirements of the Electronic Disclosure Instrument (ASIC Corporations (Electronic Disclosure) Instrument 2025/447) that is notionally imported into the definition of "nominated electronic means" (s 4). Capture server logs, email delivery receipts, portal access timestamps, or other verifiable records showing the PDS was made available and accessible at the relevant time.

4. Prepare information that describes the switch arrangement

• The instrument requires that information describing the switch arrangement be given or made available to members (ss 5(2)(d), 5A(2)(d), 5B(2)). Draft a concise, clear description of the switch mechanics, economic outcomes for affected investors, and the steps members must take. Include distribution records and timestamps showing when this information was made available.

5. Document "reasonable steps" and "reasonable grounds"

• Where relief is conditioned on "reasonable steps" (for responsible entities/operators/corporate directors) or "reasonable grounds" (for issuers relying on licence-personalised forms), document the decision-making process, the communications sent, the methods used to give/make available disclosure documents, and the contemporaneous evidence used to form the belief that applicants had access to the disclosure document. Examples: email distribution lists and delivery receipts; platform logs showing PDS downloads; screenshots of the landing page; written internal checklists and sign‑offs by compliance/legal.

6. Ensure application forms contain mandated content

• Where licence-personalised application forms are used (s 9), ensure each application form includes:
  • the identity of the issuer and the nature of the securities/financial products being offered;
  • the price of the securities (where applicable), the date of the disclosure document, and the expiry date of the disclosure document; and
  • a prominent statement that there is a disclosure document with information about investing in the securities and that it is advisable to read the disclosure document before applying (s 9(1B)(b)(i)-(ii); s 9(2B)(b)(i)-(ii)).
• Also ensure an applicant’s date of birth is on the application form or include a statement that the applicant is at least 18 (s 10).

7. Advertising and publicity compliance

• For pro‑rata bonus options, confirm advertising meets the conditions in s 7(3): pre‑lodgement advertising must include a statement that a disclosure document will be made available when the options are offered; post‑lodgement advertising must state that offers will be made in, or accompanied by, a copy of the disclosure document (s 7(3)(a)-(b)).
• For reconstructions and capital reductions, adapt advertising to the modified s 734 regime as set out in s 8 (s 8 modifies s 734 by omitting specified subparagraphs and altering paragraph 734(6)(d)). Legal review should check advertising scripts against the modified requirements.

8. Pay attention to stapled-security tests

• If relying on s 7(2) for scheme interests that are part of stapled securities, document the stapling arrangement to show that the interests and shares in a body are in the same stapled security and that no financial products in the same classes are transferable separately (s 4 definition of stapled security; s 7(2)(a)-(b)).

9. For reconstructions and capital reductions, consult technical relief

• Section 6 notes that ASIC Corporations (Capital Reductions and Reconstructions,Technical Disclosure Relief) Instrument 2017/242 provides additional technical relief. Consult that instrument to determine what additional relief applies and whether further steps or modified disclosure are required for the transaction in question (s 6 note).

10. Internal policies, training and audits

• Implement procedural checklists and staff training so that front‑line licence staff, dealer platforms and responsible-entity operations know when an application form is licence-personalised and what content must be included.
• Audit sample transactions to ensure that "reasonable grounds" and "reasonable steps" are being documented consistently and in a manner that will satisfy regulatory review.

11. Keep up to date with amendments and cross‑instruments

• The instrument has been amended several times; ensure that compliance systems reflect the current operative instrument and consult the Register for any further changes or uncommenced amendments (Endnotes 3-4). Also consult the Electronic Disclosure Instrument 2025/447, ASIC Instrument 2017/242 and the Compromises or Arrangements Instrument 2025/613 where relevant.

12. Seek legal advice for borderline cases

• Where a switch arrangement, the structure of stapling, the foreign jurisdictional mapping, or the evidence for electronic delivery is borderline, obtain legal advice. The legal question of what counts as "reasonable" or what timing constitutes the "relevant time" may be fact sensitive and would be fundamental to the availability of the relief.

Documentary evidence to keep

• PDS files with version numbers and timestamps.
• Records proving PDS availability and access (email server logs, portal access logs, download receipts).
• Copies of application forms as distributed, with the required content and timestamps.
• Records of board or corporate director sign‑offs in the case of retail CCIVs.
• Records showing how advertising complied with the modified s 734 or with s 7(3) advertising statements.

By following this operational checklist and capturing contemporaneous evidence aligned with the statutory timing requirements, issuers, responsible entities, operators and licensees materially improve their ability to rely on the instrument’s exemptions and to respond to any regulatory enquiries or disputes that may arise.